Back
Can Fite Biofarma 10K Form
Sell
42
CANF
Can Fite Biofarma
Last Price:
2.19
Seasonality Move:
-3.85%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CANF News And Ratings
See the #1 stock for the next 7 days that we like better than CANF
CANF Financial Statistics
Sales & Book Value
| Annual Sales: | $743K |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.38 |
| Price / Book: | 5.31 |
Profitability
| EPS (TTM): | -3.00000 |
|---|---|
| Net Income (TTM): | $-7.63M |
| Gross Margin: | $0 |
| Return on Equity: | -121.88% |
| Return on Assets: | -72.07% |
Can Fite Biofarma Earnings Forecast
Key Can Fite Biofarma Financial Ratios
- The Selling, General & Administrative Expenses for CANF have been equal to 397.71% of Gross Profit Margin.
- The Research & Development expenses have been 805.25% of Revenue.
- The Interest Expense is -2.49% of Operating Income.
- The Net Earning history of CANF is -1,027.46% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 9 years.
Can Fite Biofarma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CANF |
| CUSIP: | 13471N |
| Website: | canfite.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.91 |
| Quick Ratio: | 4.42 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CANF Technical Analysis vs Fundamental Analysis
Sell
42
Can Fite Biofarma (CANF)
is a Sell
Is Can Fite Biofarma a Buy or a Sell?
-
Can Fite Biofarma stock is rated a Sell
The current Can Fite Biofarma [CANF] share price is $2.16. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.